SCHEMBL4337929

SCHEMBL4337929

C=CCOC(=O)N1CCNC(C)C1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BIRC2 Q13490 1/20 0.40
HRH4 Q9H3N8 1/20 0.36
LMNA P02545 1/20 0.36
MAPK1 P28482 1/20 0.36
RAB9A P51151 1/20 0.36
FAAH O00519 3/20 0.34
ERN1 O75460 2/20 0.34
NR1D1 P20393 1/20 0.33
PARP1 P09874 1/20 0.33
MGLL Q99685 1/20 0.33
GPR119 Q8TDV5 1/20 0.32
REN P00797 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
CYP19A1 P11511 1/20 0.32
P2RY12 Q9H244 1/20 0.32
SIGMAR1 Q99720 1/20 0.31
F10 P00742 1/20 0.31
PLG P00747 1/20 0.31
PRSS1 P07477 1/20 0.31
PRSS2 P07478 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13209022 0.87 GAA (0.39) BIRC2LMNAMAPK1RAB9AFAAH
SCHEMBL2904061 0.87 GAA (0.39) BIRC2LMNAMAPK1RAB9AFAAH
SCHEMBL317572 0.82 BIRC2 (0.45) BIRC2HRH4LMNATDP1TSHR
SCHEMBL952240 0.82 BIRC2 (0.45) BIRC2HRH4LMNATDP1TSHR
SCHEMBL956554 0.82 BIRC2 (0.45) BIRC2HRH4LMNATDP1TSHR
SCHEMBL17459853 0.81 BIRC2 (0.44) BIRC2HRH4RENTP53MDM2
SCHEMBL1780077 0.80 LMNA (0.43) LMNAMAPK1RAB9AERN1GPR119
SCHEMBL4473508 0.80 BIRC2 (0.40) BIRC2HRH4RENTP53MDM2
SCHEMBL16846172 0.79 CA1 (0.38) LMNAMAPK1RAB9AFAAHERN1
Hydrochloric Acid SCHEMBL20488405 0.79 LMNA (0.42) LMNAMAPK1RAB9AERN1GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7569690-B2 Process for producing oxycarbonyl-substituted piperazine derivative TORAY FINE CHEMICALS CO., LTD. (JP) 2009-08-04 US disclosed
US-20060161003-A1 Process for producing oxycarbonyl-substituted piperazine derivative TORAY FINE CHEMICALS CO., LTD. (JP) 2006-07-20 US disclosed
EP-1548010-A1 PROCESS FOR PRODUCING OXYCARBONYL-SUBSTITUTED PIPERAZINE DERIVATIVE Toray Fine Chemicals Co., Ltd. (JP) 2005-06-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060161003-A1 Process for producing oxycarbonyl-substituted piperazine derivative DHPS, AQP4, OGFOD1 BIRC2 2491/4885HRH4 2943/4885LMNA 3673/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.